4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-015998
Chief Legal Officer sold 2,296 shares at an average $28.02 ($64,343)
- Chief Legal Officer acquired 2,296 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara Chief Legal Officer | 2023-06-15 | Option exercise | +2,269 | $23.03 | $52,255 | 32,240 | D |
| Meisner Lara Chief Legal Officer | 2023-06-15 | Sale | −2,269 | $28.02 | $63,577 | 29,971 | D |
| Meisner Lara Chief Legal Officer | 2023-06-16 | Option exercise | +27 | $23.03 | $622 | 29,998 | D |
| Meisner Lara Chief Legal Officer | 2023-06-16 | Sale | −27 | $28.35 | $765 | 29,971 | D |
| Derivatives | |||||||
| Meisner Lara Chief Legal Officer | 2023-06-15 | Option exercise · Stock Option (Right to Buy) | −2,269 | 37,481 | D | ||
| Meisner Lara Chief Legal Officer | 2023-06-16 | Option exercise · Stock Option (Right to Buy) | −28 | 37,453 | D | ||
| Open-market sales · 2,296 sh · avg $28.02 · $64,343 | |||||||
Loading xslF345X04/doc4.xml…